EUROESPES is the first European initiative to combine research and medical care in equal proportions in order to optimize scientific results and to expedite the immediate application of scientific advances for the well-being of society.

The main objectives of EUROESPES Medical Center are:

To investigate the possible causes of disorders of the Central Nervous System.

To design and implement Preventive Programs for disorders of the Central Nervous System.

To establish pioneering therapeutic strategies.

The provision of hospital and residential facilities for physically and psychically handicapped patients.

In this line of action, EUROESPES is the first group in the world to design a clinical protocol for the diagnosis of diseases of the Central Nervous System, linked with a multifactorial therapeutic strategy for senile dementia and a pharmacogenomic intervention program for Alzheimer’s disease.





EuroEspes es la primera institución española que ha realizado ensayos clínicos en Fase II con moléculas pioneras para la enfermedad de Alzheimer, que hoy compiten a nivel mundial.

EuroEspes ha desarrollado otros productos cabezas de serie internacionales y dispone de una veintena de potenciales productos en investigación, de diseño propio, para el tratamiento de patologías del Sistema Nervioso Central y otras enfermedades sistémicas de alta prevalencia en la población.